🇺🇸 FDA

Intelligence · Patent portfolio

LIGAND PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for LIGAND PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
133
Expiring ≤24m
12

Quick answer

LIGAND PHARMACEUTICALS has 133 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 12 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 3

  1. US 12403087

    Topical antiviral compositions, delivery systems, and methods of using the same

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12319651

    Crystalline forms and methods of producing crystalline forms of a compound

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12246014

    Azetidine derivatives

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12208071

    Glucagon receptor antagonists

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12123012

    Methods and compositions for nucleic acid and protein payload delivery

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11970482

    Acetal compounds and therapeutic uses thereof

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11952364

    TRK inhibitors useful as anticancer drugs

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11773110

    Heterocycle amines and uses thereof

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11566041

    Nucleotide prodrug compounds

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11413274

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11358931

    Selective androgen receptor modulators (SARMs) and uses thereof

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11278559

    Prodrug compounds and their uses

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11186593

    Heterocycle amines and uses thereof

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10975388

    Methods and compositions for nucleic acid and protein payload delivery

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10874638

    Methods and compositions for modulating hormone levels

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10736875

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10730831

    Selective androgen receptor modulators (SARMs) and uses thereof

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10604533

    Heterocycle amines and uses thereof

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10449210

    Prodrug compounds and their uses

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10441567

    Methods and compositions for modulating hormone levels

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10420748

    Methods of treatment associated with the granulocyte colony-stimulating factor receptor

    Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10150788

    Prodrug compounds and uses thereof

    Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10111859

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10106500

    Selective androgen receptor modulators (SARMs) and uses thereof

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10030034

    Heterocycle amines and uses thereof

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10000522

    Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9994600

    Prodrug compounds and uses therof

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9993461

    Method for treating disorders associated with glomerular function

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9962370

    Methods of treatment associated with the granulocyte colony-stimulating factor receptor

    Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9724374

    Capsule containing total flavonoids of desmodium styracifolium, method for preparing the same and use

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9676809

    Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9675583

    Selective androgen receptor modulators (SARMS) and uses thereof

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9662312

    Method for treating glomerulosclerosis

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9622991

    Hematopoietic growth factor mimetic small molecule compounds and their uses

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9492430

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9359285

    Androgen receptor modulator compounds and methods

    Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9326991

    Nucleotide prodrug compounds and use

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9266874

    Heterocycle amines and uses thereof

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9144557

    Hematopoietic growth factor mimetic small molecule compounds and their uses

    Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9139520

    Selective androgen receptor modulators (SARMs) and uses thereof

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8865918

    Androgen receptor modulator compounds and methods

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8822467

    Biaryl oxyacetic acid compounds

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8748633

    Selective androgen receptor modulators (SARMs) and uses thereof

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8680150

    Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8580811

    Androgen receptor modulator methods

    Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8519158

    Androgen receptor modulator compounds and methods

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8354446

    Selective androgen receptor modulators (SARMs) and uses thereof

    Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8193357

    Androgen receptor modulator compounds

    Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does LIGAND PHARMACEUTICALS have?

133 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do LIGAND PHARMACEUTICALS patents expire?

12 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.